AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · IEX Real-Time Price · USD
3.640
-0.140 (-3.70%)
At close: May 17, 2024, 4:00 PM
3.660
+0.020 (0.55%)
After-hours: May 17, 2024, 7:46 PM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.07 billion as of May 17, 2024. Its market cap has decreased by -36.97% in one year.
Market Cap
1.07B
Enterprise Value
416.88M
1-Year Change
-36.97%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $5.33B to $1.07B, a decrease of -79.88%. That is a compound annual growth rate of -37.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2024 | 1.11B | 2.16% |
| May 15, 2024 | 1.09B | -3.14% |
| May 14, 2024 | 1.12B | -0.78% |
| May 13, 2024 | 1.13B | 0.52% |
| May 10, 2024 | 1.13B | -3.04% |
| May 9, 2024 | 1.16B | 2.86% |
| May 8, 2024 | 1.13B | -4.95% |
| May 7, 2024 | 1.19B | -1.27% |
| May 6, 2024 | 1.20B | 1.98% |
| May 3, 2024 | 1.18B | 4.68% |
| May 2, 2024 | 1.13B | 1.85% |
| May 1, 2024 | 1.11B | - |
| Apr 30, 2024 | 1.11B | -1.57% |
| Apr 29, 2024 | 1.12B | 2.13% |
| Apr 26, 2024 | 1.10B | 3.58% |
| Apr 25, 2024 | 1.06B | -6.93% |
| Apr 24, 2024 | 1.14B | -1.76% |
| Apr 23, 2024 | 1.16B | -1.01% |
| Apr 22, 2024 | 1.17B | 3.62% |
| Apr 19, 2024 | 1.13B | -1.02% |
| Apr 18, 2024 | 1.14B | -0.25% |
| Apr 17, 2024 | 1.15B | -3.21% |
| Apr 16, 2024 | 1.19B | -3.11% |
| Apr 15, 2024 | 1.22B | -3.69% |
| Apr 12, 2024 | 1.27B | -0.91% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 1.13B |
| Scholar Rock Holding | 1.12B |
| Collegium Pharmaceutical | 1.11B |
| Cronos Group | 1.11B |
| Cassava Sciences | 1.10B |
| AtriCure | 1.07B |
| Arcutis Biotherapeutics | 1.07B |
| BioLife Solutions | 1.06B |